Related Experiment Video
Updated: Jun 11, 2026
07:02
A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
Understanding developmental pharmacodynamics: importance for drug development and clinical practice
1Centre for Therapeutic Evaluation of Drugs in Children, University Hospitals of Leicester, Leicester, UK. hussain.mulla@uhl-tr.nhs.uk
Paediatric Drugs
|July 3, 2010
Summary
Developmental pharmacodynamics explores how children
Area of Science:
- Pharmacology and Developmental Biology
- Pediatric Drug Development and Therapeutics
Background:
- Developmental pharmacodynamics investigates age-related changes in biological systems affecting drug response.
- Limited studies exist due to challenges in juvenile animal models and pediatric research.
- Understanding these changes is crucial for optimizing drug efficacy and safety in children.
Purpose of the Study:
- To highlight the importance of developmental pharmacodynamics in pediatric drug therapy.
- To review existing insights from animal models and clinical studies on age-dependent drug responses.
- To emphasize the need for increased research in this field for successful pediatric drug development.
Main Methods:
- Review of animal neurodevelopmental models.
- Analysis of clinical studies examining pharmacokinetic-pharmacodynamic relationships in pediatric populations.
- Exploration of age-related changes in drug potency, efficacy, and therapeutic ranges.
Main Results:
- Animal models show developmental differences in neurotransmitter systems influencing antidepressant efficacy.
- GABA(A) receptor shifts explain infant seizures with benzodiazepines.
- Neonates exhibit increased sensitivity to morphine and sotalol, and enhanced sensitivity to cyclosporine.
Conclusions:
- Age-dependent variations in drug response are evident in pediatric populations.
- Further research is essential to establish robust developmental pharmacodynamic data.
- A dual 'bottom up' and 'top down' approach is recommended for advancing pediatric drug development.
Related Concept Videos
01:21Pharmacodynamics: Overview and Principles
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:14Pharmacokinetic–Pharmacodynamic Relationship: Model Components
Pharmacokinetic-pharmacodynamic (PK–PD) modeling is essential in drug development and clinical pharmacology. It provides a quantitative framework to predict drug behavior and response over time. This approach integrates pharmacokinetics (PK), which describes the drug's absorption, distribution, metabolism, and excretion, with pharmacodynamics (PD), which characterizes the drug’s biological effects and mechanisms of action.The disposition kinetics of a drug determine its plasma...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.